ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/01/24 | 2,037 | 2,083 | 2,016 | 2,045 | -34 | -1.6% | 680,500 |
2020/01/23 | 2,095 | 2,125 | 2,050 | 2,079 | -17 | -0.8% | 496,100 |
2020/01/22 | 2,150 | 2,193 | 2,079 | 2,096 | -58 | -2.7% | 1,072,900 |
2020/01/21 | 2,184 | 2,253 | 2,147 | 2,154 | -14 | -0.6% | 999,500 |
2020/01/20 | 2,167 | 2,186 | 2,142 | 2,168 | +2 | +0.1% | 393,100 |
2020/01/17 | 2,233 | 2,233 | 2,113 | 2,166 | -34 | -1.5% | 1,116,700 |
2020/01/16 | 2,222 | 2,238 | 2,180 | 2,200 | -23 | -1% | 582,100 |
2020/01/15 | 2,190 | 2,257 | 2,182 | 2,223 | +9 | +0.4% | 673,900 |
2020/01/14 | 2,319 | 2,319 | 2,213 | 2,214 | -64 | -2.8% | 789,900 |
2020/01/10 | 2,260 | 2,303 | 2,234 | 2,278 | +25 | +1.1% | 814,900 |
2020/01/09 | 2,314 | 2,332 | 2,153 | 2,253 | +33 | +1.5% | 1,986,800 |
2020/01/08 | 2,428 | 2,453 | 2,193 | 2,220 | -258 | -10.4% | 3,404,200 |
2020/01/07 | 2,586 | 2,597 | 2,350 | 2,478 | -122 | -4.7% | 2,796,200 |
2020/01/06 | 2,580 | 2,670 | 2,531 | 2,600 | -24 | -0.9% | 1,023,100 |
2019/12/30 | 2,715 | 2,727 | 2,553 | 2,624 | -85 | -3.1% | 1,338,300 |
2019/12/27 | 2,655 | 2,724 | 2,601 | 2,709 | +72 | +2.7% | 1,344,000 |
2019/12/26 | 2,720 | 2,731 | 2,621 | 2,637 | -57 | -2.1% | 1,944,800 |
2019/12/25 | 2,548 | 2,723 | 2,536 | 2,694 | +133 | +5.2% | 2,366,800 |
2019/12/24 | 2,474 | 2,572 | 2,460 | 2,561 | +86 | +3.5% | 1,472,400 |
2019/12/23 | 2,487 | 2,510 | 2,440 | 2,475 | +3 | +0.1% | 1,126,100 |
2019/12/20 | 2,445 | 2,487 | 2,397 | 2,472 | +41 | +1.7% | 1,417,700 |
2019/12/19 | 2,445 | 2,505 | 2,381 | 2,431 | +101 | +4.3% | 2,258,600 |
2019/12/18 | 2,379 | 2,405 | 2,278 | 2,330 | -51 | -2.1% | 1,167,100 |
2019/12/17 | 2,326 | 2,428 | 2,321 | 2,381 | +105 | +4.6% | 1,679,500 |
2019/12/16 | 2,450 | 2,485 | 2,251 | 2,276 | -189 | -7.7% | 2,656,000 |
2019/12/13 | 2,426 | 2,512 | 2,410 | 2,465 | +60 | +2.5% | 2,100,900 |
2019/12/12 | 2,335 | 2,419 | 2,280 | 2,405 | +63 | +2.7% | 1,358,000 |
2019/12/11 | 2,349 | 2,410 | 2,245 | 2,342 | +19 | +0.8% | 2,346,900 |
2019/12/10 | 2,232 | 2,337 | 2,223 | 2,323 | +116 | +5.3% | 2,008,300 |
2019/12/09 | 2,169 | 2,224 | 2,130 | 2,207 | +7 | +0.3% | 1,663,500 |
2019/12/06 | 2,037 | 2,201 | 2,030 | 2,200 | +180 | +8.9% | 2,841,100 |
2019/12/05 | 1,947 | 2,077 | 1,936 | 2,020 | +95 | +4.9% | 2,061,400 |
2019/12/04 | 1,910 | 1,945 | 1,893 | 1,925 | +3 | +0.2% | 741,900 |
2019/12/03 | 1,803 | 1,922 | 1,802 | 1,922 | +85 | +4.6% | 1,155,500 |
2019/12/02 | 1,880 | 1,888 | 1,818 | 1,837 | +60 | +3.4% | 1,156,300 |
2019/11/29 | 1,746 | 1,794 | 1,746 | 1,777 | +32 | +1.8% | 511,600 |
2019/11/28 | 1,754 | 1,826 | 1,742 | 1,745 | -14 | -0.8% | 756,900 |
2019/11/27 | 1,720 | 1,768 | 1,703 | 1,759 | +46 | +2.7% | 419,100 |
2019/11/26 | 1,708 | 1,731 | 1,685 | 1,713 | +13 | +0.8% | 361,800 |
2019/11/25 | 1,666 | 1,712 | 1,640 | 1,700 | +53 | +3.2% | 409,000 |
2019/11/22 | 1,660 | 1,687 | 1,633 | 1,647 | -11 | -0.7% | 301,700 |
2019/11/21 | 1,744 | 1,745 | 1,654 | 1,658 | -85 | -4.9% | 707,200 |
2019/11/20 | 1,701 | 1,785 | 1,701 | 1,743 | +36 | +2.1% | 711,300 |
2019/11/19 | 1,653 | 1,728 | 1,648 | 1,707 | +33 | +2% | 536,300 |
2019/11/18 | 1,542 | 1,678 | 1,540 | 1,674 | +137 | +8.9% | 718,400 |
2019/11/15 | 1,700 | 1,708 | 1,518 | 1,537 | -160 | -9.4% | 1,633,400 |
2019/11/14 | 1,675 | 1,723 | 1,668 | 1,697 | +22 | +1.3% | 398,900 |
2019/11/13 | 1,719 | 1,720 | 1,648 | 1,675 | -42 | -2.4% | 447,400 |
2019/11/12 | 1,765 | 1,767 | 1,703 | 1,717 | -52 | -2.9% | 514,900 |
2019/11/11 | 1,718 | 1,774 | 1,718 | 1,769 | +51 | +3% | 387,300 |
1151~
1200
件表示中 / 3553件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 285,000円 | +52.1% | +23.3% | 0.00% | 20.21倍 | 3.87倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
科研薬 | 386,000円 | +22.8% | +113.0% | 4.92% | 10.29倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 316,000円 | +14.7% | -21.6% | 1.90% | 12.35倍 | 1.00倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
持田薬 | 348,000円 | +3.0% | +27.5% | 2.30% | 22.03倍 | 0.96倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 232,400円 | +9.6% | +17.5% | 1.98% | 13.13倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム